Barclays upgraded shares of ConvaTec Group (OTCMKTS:CNVVY – Free Report) to a strong-buy rating in a research note published on Wednesday, Zacks.com reports.
Separately, UBS Group upgraded ConvaTec Group to a strong-buy rating in a research report on Wednesday, June 26th. Three analysts have rated the stock with a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat.com, ConvaTec Group currently has an average rating of Buy and a consensus price target of $295.00.
View Our Latest Stock Report on CNVVY
ConvaTec Group Trading Down 2.5 %
ConvaTec Group Cuts Dividend
The company also recently announced a dividend, which will be paid on Monday, October 21st. Investors of record on Friday, August 23rd will be paid a dividend of $0.0584 per share. The ex-dividend date of this dividend is Friday, August 23rd.
About ConvaTec Group
ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns.
See Also
- Five stocks we like better than ConvaTec Group
- Investing in Commodities: What Are They? How to Invest in Them
- Chevron Stock Dips as Earnings Miss Highlights Merger Uncertainty
- High Dividend REITs: Are They an Ideal Way to Diversify?
- DraftKings Shares Fall After EPS Beat, Lower EBITDA Guidance
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Investors Flock to Auto Retail Stock as It Hits New Highs
Receive News & Ratings for ConvaTec Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group and related companies with MarketBeat.com's FREE daily email newsletter.